Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations.

@article{AbdelWahab2018VentricularTA,
  title={Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations.},
  author={Amir AbdelWahab and Martin J Gardner and Ratika Parkash and Christopher J Gray and John L. Sapp},
  journal={Journal of cardiovascular electrophysiology},
  year={2018},
  volume={29 1},
  pages={90-97}
}
INTRODUCTION Catheter ablation of VT in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) is often challenging, frequently requiring multiple or epicardial ablation procedures; TMEM43 gene mutations typically cause aggressive disease. We sought to compare VT ablation outcomes for ARVC patients with and without TMEM43 mutations. METHODS… CONTINUE READING